Investor Relations

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.

CR-000172

Quarterly Results

Quarterly Results

Show all

2019 Quarterly Results

2018 Quarterly Results

2017 Quarterly Results

2016 Quarterly Results

Featured Report

2018 Annual Report (PDF)

Investor Hotline

877-567-6CRL (6275)